Birmingham spin-out Serascience is acquired by Abingdon Health.

Serascience, a medical diagnostics company spun-out of Birmingham University, has been acquired by Abingdon Health.

Serascience was set up in April 2011 through Bioscience Ventures, itself a joint venture between Abingdon and Birmingham. Abingdon has raised £2.1m ($3.35m) from its shareholders as part of the acquisition.

Serascience is based on research with revolves around antibodies of the cancer myeloma and related conditions. It is currently working on putting its first product, Seralite, on the market. The device is a near-patient…